February 16, 2018 –
Technology is becoming more prevalent in practice, so it's crucial that practices choose the right technology to deliver care, said Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health.
February 15, 2018 –
Nat Turner, co-founder and CEO of Flatiron Health, says that clinical research accessibility is one of the biggest barriers in oncology care that Flatiron Health is working to remove.
February 04, 2018 –
There are a number of treatment choices available to treat patients with breast cancer and diagnostic tests can assist in the decision making, according to Adam M. Brufsky, MD, PhD, co-director of the Comprehensive Breast Cancer Center at University of Pittsburgh.
February 03, 2018 –
The changing payment and competition landscape in healthcare are the 2 biggest challenges facing community oncologists today, explained Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health.
January 30, 2018 –
Nat Turner, co-founder and CEO of Flatiron Health, explains how data can be used for finding potential patients to be included in clinical trials.
January 26, 2018 –
When looking at the value of a medication, pharmaceutical companies are looking at outcomes, including ones that encompass patient centricity, said Ira Klein, MD, MBA, FACP, senior director of healthcare quality strategy for the Strategic Customer Group at Janssen Pharmaceuticals.
January 21, 2018 –
Community oncology practices need to think outside of the box to keep up with competition and be successful, said Robin Shah, vice president of Provider Marketing and Strategy at Flatiron Health
January 10, 2018 –
Brenda Schmidt is CEO of Solera Health, an integrator that serves as the “back office” for both community-based and digital providers of the Diabetes Prevention Program (DPP), an evidence-based program that has been shown to reduce incidence of people with prediabetes progressing to type 2 diabetes. In April, Medicare will take the historic step of launching the DPP for beneficiaries, and Solera has been at the forefront of helping providers navigate the policy and technical hurdles to serve clients who will take part in the DPP.
January 04, 2018 –
Rick Doubleday is the executive vice president, and chief commercial officer at Dexcom. He is responsible for the sales, marketing and customer service functions. Previously, Doubleday led all sales and marketing functions for the company, driving the acceleration of worldwide awareness and adoption of Dexcom continuous glucose monitoring (CGM). Doubleday visited The American Journal of Managed Care® this fall to discuss bringing the Dexcom G5 to Medicare beneficiaries.
January 01, 2018 –
The biggest barriers to stopping the transmission of HIV are both the large population of infected people not receiving treatment and the lack of pre-exposure prophylaxis for high-risk individuals, said Thomas C. Quinn, MD, director of the Johns Hopkins Center for Global Health.